Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

20 janv. 2015 10h00 HE | Source: Qu Biologics;BC Cancer Agency

Qu Biologics Launches Phase 2a Clinical Trial for Non-small Cell Lung Cancer (NSCLC)

VANCOUVER, BRITISH COLUMBIA--(Marketwired - Jan. 20, 2015) - Qu Biologics Inc., a biotechnology company developing Site Specific Immunomodulators (SSIs) that aim to restore the body's...
04 déc. 2014 10h00 HE | Source: Qu Biologics

Qu Biologics Welcomes Gastroenterologist Dr. Remo Panaccione to IBD Advisory Team

VANCOUVER, BRITISH COLUMBIA--(Marketwired - Dec. 4, 2014) - Qu Biologics Inc., a biotechnology company developing Site Specific Immunomodulators (SSIs) that aim to restore normal immune...
29 oct. 2014 09h30 HE | Source: Qu Biologics

Qu Biologics' Crohn's Disease Clinical Trial Completes Independent Safety Review

VANCOUVER, BRITISH COLUMBIA--(Marketwired - Oct. 29, 2014) - Qu Biologics Inc., a biotechnology company developing Site Specific Immunomodulators (SSIs) that aim to restore the body's...
17 sept. 2014 10h05 HE | Source: Qu Biologics

Qu Biologics Closes Oversubscribed Private Funding Round of CDN$5.1 Million

VANCOUVER, BRITISH COLUMBIA--(Marketwired - Sept. 17, 2014) - Qu Biologics Inc., a biotechnology company developing Site Specific Immunomodulators (SSIs) that aim to restore the body's...
17 juin 2014 10h30 HE | Source: Qu Biologics

Qu Biologics Appoints Dr. Bob Cory as Vice President, Business Development

VANCOUVER, BRITISH COLUMBIA--(Marketwired - June 17, 2014) - Qu Biologics Inc., a biotechnology company developing Site Specific Immunomodulators (SSIs) that aim to "reboot" the body's...
04 juin 2014 10h00 HE | Source: Qu Biologics

Qu Biologics Granted Broad New Zealand Patent Involving Immunotherapies Derived from Viruses for Treating a Range of Cancers

VANCOUVER, BRITISH COLUMBIA--(Marketwired - June 4, 2014) - Qu Biologics Inc., a biotechnology company developing Site Specific Immunomodulators (SSIs) that aim to "reboot" the body's...
20 mai 2014 13h07 HE | Source: Qu Biologics

Qu Biologics Granted U.S. Patent for Use of E. coli to Treat Colon Cancer

VANCOUVER, BRITISH COLUMBIA--(Marketwired - May 20, 2014) - Qu Biologics Inc., a biotechnology company developing Site Specific Immunomodulators (SSIs) that aim to "reboot" the body's...
28 avr. 2014 14h45 HE | Source: Qu Biologics

Qu Biologics to Present Crohn's Disease Compassionate Use Results at Digestive Diseases Week Conference

VANCOUVER, BRITISH COLUMBIA--(Marketwired - April 28, 2014) - Qu Biologics Inc., a biotechnology company developing Site Specific Immunomodulators (SSIs) that aim to "reboot" the body's...
20 févr. 2014 20h49 HE | Source: Qu Biologics

Qu Biologics Opens Crohn's Disease Clinical Trial to U.S. Participants

VANCOUVER, BRITISH COLUMBIA--(Marketwired - Feb. 20, 2014) - Qu Biologics Inc., a biopharmaceutical company developing Site Specific Immunomodulators (SSIs) that aim to "reboot" the...
18 févr. 2014 09h00 HE | Source: Qu Biologics

Qu Biologics Opens Crohn's Disease Clinical Trial to U.S. Participants

VANCOUVER, BRITISH COLUMBIA--(Marketwired - Feb. 18, 2014) - Qu Biologics Inc., a biopharmaceutical company developing Site Specific Immunomodulators (SSIs) that aim to "reboot" the...

Page précédente

Page suivante